Medical Incident Report

Date of Incident: May 20, 2050

Time of Incident: 2:45 PM

Company Name: [Your Company Name]

Location: Room 305, General Hospital

Reported By: [Your Name], RN

I. Patient Involved

Name: [Patient Name]
Patient ID: 987654321
Age: 65
Gender: Male

II. Description of Incident

At approximately 2:45 PM on May 20, 2050, while administering medication to [Patient Name] in Room 305, it was observed that the patient exhibited signs of an allergic reaction. The patient developed hives and experienced difficulty breathing within minutes of receiving the medication.

III. Immediate Actions Taken

Medication Administration Halted: Upon noticing the symptoms, the administration of the medication was immediately stopped.
Emergency Response Initiated: The Rapid Response Team was notified, and they arrived within 3 minutes.
Administered Treatment: Epinephrine was administered, and the patient was given oxygen.
Monitoring: The patient was closely monitored for any further reactions.

IV. Incident Analysis

A. Cause of Incident

Initial investigation suggests that the allergic reaction may have been caused by the medication administered, which was Ceftriaxone. The patient's chart indicated a known allergy to penicillin, but there was no documented cross-reactivity to Ceftriaxone.

B. Contributing Factors

Documentation Gap: The patient's allergy profile may not have been comprehensively updated.
Communication Breakdown: Potential failure in communication between the healthcare providers regarding the patient's allergy history.

V. Follow-Up Actions

Patient Monitoring: Continuous monitoring of the patient's condition in the ICU for the next 24 hours.
Review of Allergy Documentation: A thorough review and update of the patient's medical records to ensure all allergies are accurately documented.
Staff Training: Implementation of a refresher course for all healthcare providers on the importance of reviewing patient allergy information before administering any medication.
Incident Review Meeting: A meeting is scheduled with the healthcare team involved to discuss the incident and identify measures to prevent future occurrences.

VI. Witness Statements

Witness 1:
Name: Dr. Emily Johnson
Position: Attending Physician
Statement: "Upon arrival, the patient was in respiratory distress. Immediate administration of epinephrine was necessary, and the patient's condition stabilized shortly after."

Witness 2:
Name: Mark Lee
Position: Pharmacist
Statement: "The prescribed medication was Ceftriaxone, typically considered safe unless contraindicated by specific allergies, which in this case was not adequately cross-referenced."

VII. Recommendations

Enhanced Screening: Implement a mandatory double-check system for allergy verification before medication administration.
Improved Communication: Establish a protocol for mandatory verbal confirmation of patient allergies during shift changes.
Technological Support: Utilize electronic health record (EHR) systems more effectively to flag potential allergy interactions in real-time.